Inspire Medical Systems (NYSE:INSP) VP Sells $98,960.00 in Stock

Inspire Medical Systems (NYSE:INSP) VP Steven Jandrich sold 1,000 shares of the firm’s stock in a transaction on Tuesday, July 21st. The stock was sold at an average price of $98.96, for a total value of $98,960.00. Following the completion of the sale, the vice president now directly owns 2,805 shares of the company’s stock, valued at approximately $277,582.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Steven Jandrich also recently made the following trade(s):

  • On Tuesday, June 23rd, Steven Jandrich sold 1,000 shares of Inspire Medical Systems stock. The stock was sold at an average price of $96.39, for a total transaction of $96,390.00.

INSP opened at $99.74 on Friday. The company’s 50-day simple moving average is $90.98 and its two-hundred day simple moving average is $77.77. The company has a debt-to-equity ratio of 0.19, a quick ratio of 10.80 and a current ratio of 11.33. The stock has a market capitalization of $2.66 billion, a P/E ratio of -58.33 and a beta of 1.33. Inspire Medical Systems has a 52-week low of $40.53 and a 52-week high of $105.54.

Inspire Medical Systems (NYSE:INSP) last issued its earnings results on Tuesday, May 5th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.57) by ($0.10). The company had revenue of $21.30 million during the quarter, compared to analysts’ expectations of $21.35 million. Inspire Medical Systems had a negative return on equity of 29.14% and a negative net margin of 47.30%. The company’s revenue for the quarter was up 30.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.35) EPS. Research analysts forecast that Inspire Medical Systems will post -3.05 EPS for the current fiscal year.

A number of research firms recently issued reports on INSP. Zacks Investment Research downgraded shares of Inspire Medical Systems from a “hold” rating to a “sell” rating in a research note on Friday, July 3rd. Piper Sandler increased their target price on Inspire Medical Systems from $81.00 to $98.00 and gave the stock an “overweight” rating in a research report on Thursday, June 18th. Lake Street Capital started coverage on Inspire Medical Systems in a report on Monday, May 18th. They issued a “buy” rating and a $90.00 price objective for the company. SVB Leerink boosted their target price on shares of Inspire Medical Systems from $85.00 to $110.00 and gave the company an “outperform” rating in a report on Monday, June 29th. Finally, Bank of America raised shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and set a $90.00 target price on the stock in a research report on Tuesday, April 28th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $86.17.

Several institutional investors and hedge funds have recently modified their holdings of INSP. Ziegler Capital Management LLC grew its position in Inspire Medical Systems by 3.0% during the second quarter. Ziegler Capital Management LLC now owns 5,039 shares of the company’s stock valued at $438,000 after buying an additional 145 shares during the period. Flagship Harbor Advisors LLC lifted its position in Inspire Medical Systems by 54.5% during the first quarter. Flagship Harbor Advisors LLC now owns 425 shares of the company’s stock valued at $26,000 after purchasing an additional 150 shares in the last quarter. Rhumbline Advisers grew its holdings in Inspire Medical Systems by 1.2% during the first quarter. Rhumbline Advisers now owns 19,779 shares of the company’s stock valued at $1,192,000 after purchasing an additional 241 shares during the period. Swiss National Bank increased its position in Inspire Medical Systems by 1.7% in the first quarter. Swiss National Bank now owns 23,300 shares of the company’s stock worth $1,405,000 after buying an additional 400 shares in the last quarter. Finally, Diversified Trust Co raised its stake in shares of Inspire Medical Systems by 13.7% in the second quarter. Diversified Trust Co now owns 4,520 shares of the company’s stock worth $393,000 after buying an additional 545 shares during the period. 86.78% of the stock is owned by institutional investors.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Further Reading: Moving Average – How it Helps Investors in Stock Selection

Insider Buying and Selling by Quarter for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.